Ratio of cyclin-dependent kinase 1 (CDK1) activity to CDK2 activity after ex vivo paclitaxel treatment predicts response to paclitaxel in human breast cancer

被引：0
|
作者：
Kim, S. J.
Taguchi, T.
Tamaki, Y.
Tsukamoto, F.
Akazawa, K.
Ueno, N. T.
Hortobagyi, G. N.
Nakayama, S.
Torikoshi, Y.
Gohda, K.
Ishihara, H.
Noguchi, S.
机构：
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
[2] Osaka Koseinenkin Hosp, Osaka, Japan
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Sysmex Corp, Kobe, Hyogo, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：366S / 366S
页数：1
相关论文
共 50 条
  • [31] Proapoptotic role of CDK1 in overcoming paclitaxel resistance in ovarian cancer cells in response to combined treatment with paclitaxel and duloxetine
    Kim, Gyeongmi
    Jang, Se-Kyeong
    Ahn, Se Hee
    Kim, Selim
    Park, Chan Sub
    Seong, Min-Ki
    Kim, Hyun-Ah
    Bae, Seunghee
    Lee, Jae Ho
    Kim, Hyunggee
    Jin, Hyeon-Ok
    Park, In-Chul
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [32] Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception
    Giarolla, Jeanine
    Holdaway, Kelsey A.
    Nazari, Maryam
    Aiad, Laila
    Sarkar, Bidisha
    Georg, Gunda I.
    FUTURE MEDICINAL CHEMISTRY, 2025, 17 (05) : 607 - 627
  • [33] Cyclin-dependent kinase activity is required for progesterone receptor function: Novel role for cyclin A/Cdk2 as a progesterone receptor coactivator
    Narayanan, R
    Adigun, AA
    Edwards, DP
    Weigel, NL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (01) : 264 - 277
  • [34] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    M Matsumoto
    M Furihata
    T Ishikawa
    Y Ohtsuki
    S Ogoshi
    British Journal of Cancer, 1999, 80 : 256 - 261
  • [35] Flavopiridol induces G(1) arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells
    Carlson, BA
    Dubay, MM
    Sausville, EA
    Brizuela, L
    Worland, PJ
    CANCER RESEARCH, 1996, 56 (13) : 2973 - 2978
  • [36] Cell-free degradation of p27kip1, a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
    Nguyen, H
    Gitig, DM
    Koff, A
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (02) : 1190 - 1201
  • [37] Monitoring cyclin-dependent kinase 2 (CDK2) activity with Kinase-Glo, a luminescence-based ATP quantitative reagent
    Liu, Qi
    Gao, Jinlan
    Liu, Xing
    Wang, Shusen
    Luo, Yang
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (07): : 1217 - 1220
  • [38] The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1
    Beaujois, Remy
    Ottoni, Elizabeth
    Zhang, Xin
    Gagnon, Christina
    HSine, Sami
    Mollet, Stephanie
    Viranaicken, Wildriss
    DesGroseillers, Luc
    BMC CELL BIOLOGY, 2017, 18
  • [39] The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1
    Rémy Beaujois
    Elizabeth Ottoni
    Xin Zhang
    Christina Gagnon
    Sami HSine
    Stéphanie Mollet
    Wildriss Viranaicken
    Luc DesGroseillers
    BMC Cell Biology, 18
  • [40] Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor
    Taeg Kyu Kwon
    Albert A Nordin
    Oncogene, 1998, 16 : 755 - 762
12345